文献速递肾移植

肾移植受者激素减量后他克莫司暴露增加受CYP3A5和PXR基因多态性影响

Increase in tacrolimus exposure after steroid tapering is influenced by CYP3A5 and pregnane X receptor genetic polymorphisms in renal transplant recipients.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究在83例肾移植受者中分析CYP3A5和PXR单核苷酸多态性对激素减量后他克莫司剂量归一化谷浓度变化的影响,采用线性回归。发现CYP3A5*3/*3基因型及PXR G7635G个体激素减量后剂量归一化谷浓度增加更显著,且两基因间无交互作用。

要点

  • CYP3A5*3/*3较*1/*3基因型激素减量后他克莫司剂量归一化谷浓度增加更显著。
  • PXR G7635G个体激素减量后他克莫司剂量归一化谷浓度增加显著。
  • CYP3A5与PXR SNP间无交互作用,PXR独立影响他克莫司代谢。

核心结论

  • 肾移植后激素减量所致他克莫司剂量归一化谷浓度增加幅度与CYP3A5 SNP相关。
  • PXR G7635G SNP独立与这种增加相关,证实PXR在他克莫司代谢中的作用。

研究设计与样本

  • 队列研究,纳入83例肾移植后至少6周、他克莫司和激素治疗处于药代动力学稳态且血液可用于基因分析的门诊患者。
  • 采用线性回归分析CYP3A5和PXR SNP(A7635G、C8055T、C25385T)对激素减量后剂量归一化他克莫司谷浓度的影响及交互作用。

主要发现

  • 与CYP3A5*1/*3基因型相比,CYP3A5*3/*3基因型激素减量后剂量归一化谷浓度增加更强(+0.29 µg/L/mg;P=0.002)。
  • PXR G7635G个体较A7635A激素减量后剂量归一化谷浓度增加更强(+0.31 µg/L/mg;P=0.02)。
  • A7635G杂合子增加较弱(+0.17 µg/L/mg;P=0.124)。
  • CYP3A5与PXR SNP间无交互作用也无关联。

临床怎么用

  • 肾移植受者激素减量时,可考虑CYP3A5和PXR基因型指导他克莫司剂量调整。
  • 尤其CYP3A5*3/*3或PXR G7635G个体激素减量后他克莫司暴露可能增加更明显,需加强监测。

局限性

  • 样本量83例,结果需更大样本验证。
  • 仅分析三个PXR SNP,未覆盖其他可能位点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tacrolimus, a drug for prevention of rejection after kidney transplantation, has a narrow therapeutic window and is metabolized by the cytochrome P540 3A (CYP3A) system. Tacrolimus exposure increases after steroid tapering in many patients. The pregnane X receptor (PXR)-a mediator for CYP3A-has a steroid receptor and might regulate CYP3A5 activity depending on single nucleotide polymorphisms (SNPs) of CYP3A5 or PXR. This may contribute to differences in tacrolimus exposure after steroid tapering. METHODS: In a cohort of renal transplant recipients, the influence of CYP3A5 and PXR SNPs (A7635G, C8055T and C25385T) on the dose-normalized Tacrolimus trough concentration (DnC0) and their potential interaction with each other after steroid taper were analysed by linear regression. Eligible were all 83 outpatient renal transplant patients on tacrolimus and steroids in a pharmacokinetic steady state at least 6 weeks after transplantation and whose blood was available for genetic analysis. RESULTS: Compared with the CYP3A5*1/*3 genotype, the CYP3A5*3/*3 SNP showed a significantly stronger increase in DnC0 after steroid taper (+0.29 µg/L/mg; P = 0.002). Of the tested PXR SNPs, PXR G7635G individuals had a significantly stronger increase in DnC0 (compared with A7635A, +0.31 µg/L/mg; P = 0.02), with a weaker increase in A7635G heterozygotes (+0.17 µg/L/mg; P = 0.124). There was neither interaction nor association between CYP3A5 and PXR SNPs. CONCLUSIONS: The magnitude of the DnC0 increase due to steroid taper after renal transplantation is related to CYP3A5 SNPs. Independently, the PXR G7635G SNP is related to this increase, proving the role of PXR in tacrolimus metabolism.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Stifft F, van Kuijk SMJ, Bekers O, et al. Increase in tacrolimus exposure after steroid tapering is influenced by CYP3A5 and pregnane X receptor genetic polymorphisms in renal transplant recipients. Nephrol Dial Transplant. 2018. PMID: 29733390. doi:10.1093/ndt/gfy096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。